Cart
sales@molnova.com
Mutant EGFR inhibitor
CAS No. 1421373-62-7
Mutant EGFR inhibitor( MDK3627 | MDK 3627 | Mutant EGFR inhibitor )
Catalog No. M17288 CAS No. 1421373-62-7
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 84 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 349 | In Stock |
|
| 50MG | 519 | In Stock |
|
| 100MG | 743 | In Stock |
|
| 500MG | 1512 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMutant EGFR inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionMutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
-
DescriptionMDK3627, also known as Mutant EGFR inhibitor, is a selective and potent Mutated EGFR inhibitor(L858R activating mutant.
-
In Vitro——
-
In Vivo——
-
SynonymsMDK3627 | MDK 3627 | Mutant EGFR inhibitor
-
PathwayOthers
-
TargetPlatelet aggregation
-
RecptorEGFR (mutant)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1421373-62-7
-
Formula Weight520.03
-
Molecular FormulaC27H30ClN7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL. 96.15 mM; H2O : < 0.1 mg/mL
-
SMILESCOc1c(Nc2ncc(Cl)c(n2)c2c[nH]c3ccccc23)cc(NC(=O)C=C)c(c1)N(C)CCN(C)C
-
Chemical Name(Z)-N-(5-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylimidic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Carbasalate?Calcium
Carbasalate calcium?is an?analgesic,?antipyretic, and?anti-inflammatory?drug,?as well as a?platelet aggregation inhibitor.?
-
Benzcyclane
Benzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.
-
ethyl 1-[(4-cyanoben...
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate is a platelet aggregation inhibitor.
